Literature DB >> 24741026

Obesity and thyroid cancer.

Marjory Alana Marcello1, Lucas Leite Cunha2, Fernando Assis Batista2, Laura Sterian Ward2.   

Abstract

Many studies have provided observational data on the association of obesity and thyroid cancers, but only few of them propose mechanisms that would permit a better understanding of the causal molecular mechanisms of this association. Considering that there is an increasing incidence of both obesity and thyroid cancers, we need to summarize and link recent studies in order to characterize and understand the contribution of obesity-related factors that might affect thyroid cancer development and progression. Adipose tissue is involved in many vital processes, including insulin sensitivity, angiogenesis, regulation of energy balance, activation of the complement system, and responses such as inflammation. Although these processes have their own molecular pathways, they involve the same molecules through which obesity and adipose tissue might exert their roles in carcinogenesis, not only affecting MAPK and PI3K or even insulin pathways, but also recruiting local inflammatory responses that could result in disease formation and progression. This review describes five important issues that might explain the link between excessive weight and thyroid cancer: thyroid hormones, insulin resistance, adipokines, inflammation, and sexual hormones.
© 2014 Society for Endocrinology.

Entities:  

Keywords:  molecular biology; obesity; oncology

Mesh:

Substances:

Year:  2014        PMID: 24741026     DOI: 10.1530/ERC-14-0070

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  31 in total

Review 1.  Linking obesity-induced leptin-signaling pathways to common endocrine-related cancers in women.

Authors:  Eunice Nyasani; Iqbal Munir; Mia Perez; Kimberly Payne; Salma Khan
Journal:  Endocrine       Date:  2018-09-14       Impact factor: 3.633

2.  Is body mass index relevant to prognosis of papillary thyroid carcinoma? A clinicopathological cohort study.

Authors:  Yoo Seung Chung; Joon-Hyop Lee; Young Don Lee
Journal:  Surg Today       Date:  2016-09-21       Impact factor: 2.549

Review 3.  Growing incidence of thyroid carcinoma in recent years: Factors underlying overdiagnosis.

Authors:  Alvaro Sanabria; Luiz P Kowalski; Jatin P Shah; Iain J Nixon; Peter Angelos; Michelle D Williams; Alessandra Rinaldo; Alfio Ferlito
Journal:  Head Neck       Date:  2017-12-05       Impact factor: 3.147

4.  Associations between body mass and papillary thyroid cancer stage and tumor size: a population-based study.

Authors:  Peter Dieringer; Evan M Klass; Brenna Caine; Julie Smith-Gagen
Journal:  J Cancer Res Clin Oncol       Date:  2014-08-12       Impact factor: 4.553

5.  Changing patterns of thyroid cancer in different stages of Universal Salt Iodization in Peking Union Medical College Hospital, 1986-2018.

Authors:  Ziyang Zeng; Kang Li; Weiming Kang; Jianchun Yu; Xianze Wang; Zimu Zhang; Juan Sun; Siwen Ouyang
Journal:  Gland Surg       Date:  2020-10

Review 6.  Current status and future perspectives in differentiated thyroid cancer.

Authors:  Tae Yong Kim; Won Gu Kim; Won Bae Kim; Young Kee Shong
Journal:  Endocrinol Metab (Seoul)       Date:  2014-09

7.  Polymorphisms of IL-4 and IL-4R are associated to some demographic characteristics of differentiated thyroid cancer patients but are not determinants of risk in the Brazilian population.

Authors:  Mariana Bonjiorno Martins; Fernando de Assis Batista; Natassia Elena Bufalo; Karina Colombera Peres; Murilo Meneghetti; Ligia Vera Montali da Assumpção; Laura Sterian Ward
Journal:  Endocrine       Date:  2020-09-09       Impact factor: 3.633

8.  The role of metabolic setting in predicting the risk of early tumour relapse of differentiated thyroid cancer (DTC).

Authors:  Chiara Mele; Marina Caputo; Maria Teresa Samà; Valentina Bullara; Maria Grazia Mauri; Flavia Prodam; Gianluca Aimaretti; Loredana Pagano; Paolo Marzullo
Journal:  Eur J Clin Nutr       Date:  2020-06-09       Impact factor: 4.016

Review 9.  Association of BMI with Clinicopathological Features of Papillary Thyroid Cancer: A Systematic Review and Meta-Analysis.

Authors:  R J O'Neill; S Abd Elwahab; M J Kerin; A J Lowery
Journal:  World J Surg       Date:  2021-06-16       Impact factor: 3.352

10.  Low urinary iodine is a protective factor of central lymph node metastasis in papillary thyroid cancer: a cross-sectional study.

Authors:  Ziyang Zeng; Kang Li; Xianze Wang; Siwen Ouyang; Zimu Zhang; Zhen Liu; Juan Sun; Xin Ye; Weiming Kang; Jianchun Yu
Journal:  World J Surg Oncol       Date:  2021-07-12       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.